Lanean...
Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia
BACKGROUND: Alopecia has become a very common disease that many people around the world are suffered. Minoxidil (MXD) is the most well-known commercialized drug in its treatment. However, in the case of MXD administration, there are some problems with low efficiency of transdermal delivery and addit...
Gorde:
| Argitaratua izan da: | Biomater Res |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824046/ https://ncbi.nlm.nih.gov/pubmed/31695925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40824-019-0164-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|